Literature DB >> 29967930

Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia.

S A Bowden1, B H Adler2.   

Abstract

Entities:  

Keywords:  Asfotase alfa; Bone radiograph; Hypophosphatasia

Mesh：

Substances：

Year:  2018        PMID： 29967930     DOI： 10.1007/s00198-018-4613-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  4 in total

Review 1.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

2.  Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.

Authors:  S A Bowden; B H Adler
Journal:  Osteoporos Int       Date:  2017-10-18       Impact factor: 4.507

Review 3.  Hypophosphatasia: An overview For 2017.

Authors:  Michael P Whyte
Journal:  Bone       Date:  2017-02-24       Impact factor: 4.398

Review 4.  The role of phosphatases in the initiation of skeletal mineralization.

Authors:  José Luis Millán
Journal:  Calcif Tissue Int       Date:  2012-11-27       Impact factor: 4.333
  4 in total
  9 in total

1.  New therapeutic options for bone diseases.

Authors:  Roland Kocijan; Judith Haschka; Julia Feurstein; Jochen Zwerina
Journal:  Wien Med Wochenschr       Date:  2021-01-29

2.  Multidisciplinary Management of Infantile Hypophosphatasia Resulting in Radiographic and Clinical Improvement: A Case Report.

Authors:  Leeann Qubain; Pamela Smith; Neeraj Vij; Mohan Belthur
Journal:  Cureus       Date:  2022-05-28

Review 3.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

Review 4.  Hypophosphatasia: From Diagnosis to Treatment.

Authors:  Sebastian Simon; Heinrich Resch; Klaus Klaushofer; Paul Roschger; Jochen Zwerina; Roland Kocijan
Journal:  Curr Rheumatol Rep       Date:  2018-09-10       Impact factor: 4.592

Review 5.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  Hypophosphatasia: A Case of Two Patients With Spinal Cord Compression From Increase in Ligamentous Ossifications During Treatment.

Authors:  Michel Laroche; Guillaume Couture; Marie Faruch; Adeline Ruyssen-Witrand; Valérie Porquet-Bordes; Jean Pierre Salles; Yannick Degboe
Journal:  JBMR Plus       Date:  2021-03-05

Review 7.  Hypophosphatasia.

Authors:  Symeon Tournis; Maria P Yavropoulou; Stergios A Polyzos; Artemis Doulgeraki
Journal:  J Clin Med       Date:  2021-12-01       Impact factor: 4.241

8.  Impact of discontinuing 5 years of enzyme replacement treatment in a cohort of 6 adults with hypophosphatasia: A case series.

Authors:  Cheryl Rockman-Greenberg; Robert Josse; Mira Francis; Aziz Mhanni
Journal:  Bone Rep       Date:  2022-08-30

Review 9.  Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.

Authors:  Sasigarn A Bowden; Brian L Foster
Journal:  Drug Des Devel Ther       Date:  2018-09-24       Impact factor: 4.162
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.